Merck & Co., Inc. - Company & Market Research Reports

Home /
Companies /
Merck & Co., Inc.

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 331
Infectious Diseases Drugs 244
Vaccines 240
Animal Healthcare/Veterinary 193
Endocrine and Metabolic Disorders Drugs 174
Immune Disorders Drugs 152
Women's Health 136
Animal Pharmaceuticals 132
Central Nervous System Drugs 132
Cardiovascular Drugs 123
Pharmaceuticals 115
Drug Discovery 109
Musculoskeletal Disorders Drugs 105
Biopharmaceuticals 93
Respiratory Drugs 82
Clinical Trials 77
Oncology 74
Sexual and Reproductive Health Drugs 72
Allergy and Immunology 71
Liver and Kidney Disorders Drugs 69
Diabetes Drugs 67
Drug Delivery 61
Antibiotics 61
Biotechnology 60
Gastrointestinal Drugs 59
Enzymes 57
Genomics 52
Brain Cancer Drugs 43
Optical Disorders Drugs 42
Analgesics 42
Dermatological Drugs 42
Skin Cancer Drugs 38
Infusions and Injectables 37
Diagnostics 37
Pulmonary Medicine 35
Lymphoma Drugs 35
Cancer Vaccines 33
Biosimilars and Biosuperiors 33
Pharmaceutical Intermediates 32
Hematological Drugs 31
Urological Disorders Drugs 30
Lung Cancer Drugs 29
Pharmaceutical Manufacturing 29
Optical 27
HIV/AIDS Drugs 27
Liver Cancer Drugs 26
Over the Counter (OTC) Drugs 26
Healthcare Services 25
Prostate Cancer Drugs 24
Neurology 23
Infectious Disease Testing 23
Cervical Cancer Drugs 22
Allergy Drugs 22
Immunosuppressive Drugs 22
Breast Cancer Drugs 21
Leukemia Drugs 21
Cardiology 21
Mental Disorders Drugs 19
Psoriasis Drugs 19
Asthma Drugs 18
Colon Cancer Drugs 17
Bladder Cancer Drugs 17
Drugs by Therapeutic Area 16
Inhalers and Nebulisers 16
Dermatology 16
Vitamins and Dietary Supplements 16
Biomarkers 15
E-Healthcare 14
Fertility Services 14
Hematology 14
Pediatrics 14
Alzheimer's Disease Drugs 14
Ovarian Cancer Drugs 13
Medical Devices 13
Pancreatic Cancer Drugs 13
Gastroenterology 13
Urology and Nephrology 12
Nanomedicine 12
Anti-Obesity Drugs 12
Therapeutic Area 11
Generic Drugs 11
Kidney Cancer Drugs 11
In Vitro Diagnostics 10
Transdermal and Transmucosal Drug Delivery 10
Respiratory Devices 10
Thyroid Cancer Drugs 10
Anesthetic Drugs 8
Mental Health 8
Endocrinology 7
Bronchitis Drugs 7
Hepatology 6
Healthcare 6
Needles and Syringes 6
Uterine Cancer Drugs 6
Other Healthcare Facilities 6
Laboratory Equipment 6
Company Reports 5
Proteomics 5
Cough and Cold Drugs 4
Surgical Procedures 4
Molecular Diagnostics 4
Cardiovascular Devices 3
Diabetes Devices 3
Hospital Management 3
Acne Drugs 3
Anxiety Drugs 3
Schizophrenia Drugs 3
Addiction Disorders Drugs 2
Patient Monitoring Equipment 2
Pharmacoeconomics 2
Laboratory Testing 2
Dental 2
Mammography 2
Blood Banking 2
Biomaterials 2
ENT Devices 2
Nursing 2
Surgical Devices 2
Endoscopy 2
Clinical Skills 2
Palliative Care 2
Maternal and Neonatal Care 2
Orthopedic Devices 1
Dialysis 1
Cholesterol Testing 1
Managed Care 1
Wound Care 1
Stem Cells 1
Neurology Devices 1
Contrast Media 1
Nuclear Medicine and Radiopharmacology 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

3,393 Results (Page 135 of 170)
- Relevance
  Sort by

Allogeneic Cell Therapy Market - Distribution by Type of Cell Therapy, Source of Cell, Target Indication, Therapeutic Area and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

 Report
July 2023
205 Pages
Global

From

€5277EUR$5,899USD£4,640GBP

Interventional Oncology Devices Market Report 2025

 Report
March 2025
250 Pages
Global

From

€4017EUR$4,490USD£3,532GBP

Multiple Sclerosis Therapeutics - Global Strategic Business Report

 Report
November 2025
268 Pages
Global

From

€5233EUR$5,850USD£4,601GBP

Catecholamines - Global Strategic Business Report

 Report
November 2025
372 Pages
Global

From

€5233EUR$5,850USD£4,601GBP

Blarcamesine - Global Strategic Business Report

 Report
November 2025
370 Pages
Global

From

€5233EUR$5,850USD£4,601GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Learning Disabilities Treatment - Global Strategic Business Report

 Report
November 2025
388 Pages
Global

From

€5233EUR$5,850USD£4,601GBP

Levodopa - Global Strategic Business Report

 Report
November 2025
377 Pages
Global

From

€5233EUR$5,850USD£4,601GBP

Plexiform Neurofibromas Treatment - Global Strategic Business Report

 Report
November 2025
372 Pages
Global

From

€5233EUR$5,850USD£4,601GBP

Central Nervous System Therapeutics - Global Strategic Business Report

 Report
November 2025
395 Pages
Global

From

€5233EUR$5,850USD£4,601GBP

Neuralgia Treatment - Global Strategic Business Report

 Report
November 2025
276 Pages
Global

From

€5233EUR$5,850USD£4,601GBP

Facial Palsy - Global Strategic Business Report

 Report
November 2025
367 Pages
Global

From

€5233EUR$5,850USD£4,601GBP

Insomnia Drugs - Global Strategic Business Report

 Report
November 2025
189 Pages
Global

From

€5233EUR$5,850USD£4,601GBP

Parkinson's Disease Drugs - Global Strategic Business Report

 Report
November 2025
382 Pages
Global

From

€5233EUR$5,850USD£4,601GBP

Barbiturate Drugs - Global Strategic Business Report

 Report
November 2025
386 Pages
Global

From

€5233EUR$5,850USD£4,601GBP

Frontotemporal Dementia - Global Strategic Business Report

 Report
November 2025
381 Pages
Global

From

€5233EUR$5,850USD£4,601GBP

Hairy Cell Leukemia Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

 Report
April 2023
110 Pages
Global

From

€4249EUR$4,750USD£3,736GBP

Inflammatory Bowel Disease Treatment Market Report 2025

 Report
September 2025
250 Pages
Global

From

€4017EUR$4,490USD£3,532GBP

Antithrombotic/Anticoagulant Drugs: Technologies and Global Markets

 Report
October 2023
157 Pages
Global

From

€4160EUR$4,650USD£3,657GBP

Glioma - Competitive Landscape, 2023

 Report
April 2023
450 Pages
Global

From

€2326EUR$2,600USD£2,045GBP

€2907EUR$3,250USD£2,556GBP

Glioma - Market Insight, Epidemiology And Market Forecast - 2032

 Report
April 2023
394 Pages
Global

From

€5368EUR$6,000USD£4,719GBP

€6710EUR$7,500USD£5,899GBP

3,393 Results (Page 135 of 170)
- 1
- 133
- 134
- 135
- 136
- 137

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.